ArticleTranslational lung cancer research2023

Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited.

Marc G Denis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.